Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses data from SITC, the strategy to take Efti to market and milestones for 2023.
Immutep (ASX:IMM) delivering strong data in first-line non-small cell lung cancer
- 2023.03.01
- THE FIRST TAKE
